logo
v4.0
登录 注册
登记号
试验题目
招募状态
适应症
干预措施
试验分期
申办者
首次提交时间
CAPIVASERTIB REGULATORY POSTMARKETING SURVEILLANCE IN KOREA
Not yet recruiting
Breast Cancer
AstraZeneca
2025-04-14
A Long-term Trial of EB-1020 in Adult Patients With ADHD
Recruiting
Attention Deficit Hyperactivity Disorder (ADHD)
EB-1020 (Centanafadine) 164.4 mg;EB-1020 (Centanafadine) 328.8 mg
Phase 3
Otsuka Pharmaceutical Co., Ltd.
2025-04-11
Prospective Comparison of Acellular Dermal Matrix and Autologous Tarsus for Correction of Lower Eyelid Retraction
Recruiting
Lower Eyelid Retraction
Surgical implantation in the lower eyelid of graft
N/A
Haukeland University Hospital
2025-04-11
Universal Genetic Testing for Cancer Risk Reduction
Recruiting
Genetic Testing
Natera® Empower™ hereditary cancer panel test;Specialist Referral
N/A
NYU Langone Health
2025-04-11
Baricitinib in the Treatment of Kohlmeier-Degos Disease in Patients With Neurological Involvement
Recruiting
Kohlmeier-Degos Disease;Malignant Atrophic Papulosis;Degos Disease;Papulosis, Malignant Atrophic
Baricitinib
Phase 2
National Heart, Lung, and Blood Institute (NHLBI)
2025-04-10
A Study to Evaluate Efficacy and Safety of HS-10374 for Mild-to-moderate Plaque Psoriasis
Not yet recruiting
Psoriasis
HS-10374 6mg tablets;HS-10374-matched placebo tablets
Phase 2
Hansoh BioMedical R&D Company
2025-04-10
Clinical Feasibility of the BinaxNOW™ COVID-19/Flu A&B Combo in the Southern Hemisphere
Not yet recruiting
Influenza Type A;Influenza Type B;COVID-19
BinaxNOW™ COVID-19/Flu A&B Combo Self-Test
N/A
Abbott Rapid Dx
2025-04-10
Zanzalintinib Maintenance in Patients With High Grade Neuroendocrine Neoplasms (HG-NENs)
Not yet recruiting
High Grade Neuroendocrine Neoplasms
Zanzalintinib
Phase 2
Washington University School of Medicine
2025-04-10
Allogeneic HSCT With Low-Dose Post-Transplant Cyclophosphamide for GVHD Prevention
Not yet recruiting
Graft-versus-Host Disease (GVHD);Hematologic Malignancies;Allogeneic Stem Cell Transplantation
Cyclophosphamide (primary intervention for GVHD prophylaxis)
Phase 2
Milton S. Hershey Medical Center
2025-04-10
Efficacy and Safety of Endovascular Thrombectomy in Acute Ischemic Stroke With Posterior Circulation Large Infarct
Enrolling by invitation
Acute Basilar Artery Occlusion;Posterior Circulation Large Infarct
Endovascular Thrombectomy (EVT)
Feng Gao
2025-04-10
Neuroendoscopic Hematoma Evacuation Combined With Methylprednisolone Sodium Succinate in the Treatment of Lobar Intracerebral Hemorrhage at the Early Stage.
Not yet recruiting
Stroke;Intracerebral Hemorrhage Lobar;Methylprednisolone;Surgery
Simple neuroendoscopic hematoma evacuation;Neuroendoscopic hematoma evacuation combined with sodium methylprednisolone succinate
Phase 4
Yong Jiang
2025-04-09
Association of Nutritional Status With Immune Checkpoint Inhibitor Efficacy in Metastatic Metastatic Esophagogastric Cancer.
Enrolling by invitation
Gastric Neoplasm;Esophageal Adenosquamous Carcinoma
Exposure: Nutritional Status;Exposure: Nutritional Status
Yongxu Jia
2025-04-09
Heat thErapy And mobiLity in COVID-19 Survivors
Not yet recruiting
Long COVID
Heat therapy;Sham Control;Walking
N/A
University of Nebraska
2025-04-09
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Inhaled XQ-001 in Healthy Subjects
Active, not recruiting
Healthy
Part A - single rising dose 1;Part A - single rising dose 2;Part A - single rising dose 3;Part A - single rising dose 4;Part A - single rising dose 5;Part A - single rising dose 6;Part B - mutiple rising dose 1;Part B - mutiple rising dose 2
Phase 1
Brilliant Inspiration Biotherapeutics
2025-04-08
A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer
Not yet recruiting
Triple Negative Breast Cancer
Sacituzumab Govitecan-hziy (SG)
Phase 1/Phase 2
Gilead Sciences
2025-04-08
A Multicenter RCT of "3+7" vs Venetoclax + CACAG in Newly Diagnosed Mid/High-Risk AML Patients
Recruiting
Acute Myeloid Leukemia;First Line Therapy
Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor;"3+7"
Phase 2
Chinese PLA General Hospital
2025-04-08
R-MVST Cells for Treatment of Viral Infections in Children and Young Adults
Not yet recruiting
Epstein-Barr Virus;Cytomegalovirus Infections;Adenovirus;BK Virus Infection;Immune Deficiency
Rapidly generated virus specific T (R-MVST) cells
Phase 1
Columbia University
2025-04-08
Ophtalmological Characteristics of Patients With Craniosynostosis Followed at the Amiens University Hospital
Recruiting
Craniosynostosis;Strabismus;Intracranial Hypertension;Amblyopia
Centre Hospitalier Universitaire, Amiens
2025-04-08
The Effect of Teaching Methods on Urinary Catheterization Application Knowledge, Skills and Self-Efficient Level of Nursing Students
Completed
Nursing Students
Experimental;Experimental
N/A
Inonu University
2025-04-08
Ivonescimab in Combination With Docetaxel in Advanced Non-Small Cell Lung Cancer
Not yet recruiting
Non-Small Cell Lung Cancer
Ivonescimab, docetaxel;Placebo, docetaxel
Phase 3
Akeso
2025-04-08
%s %s
共 527778 条 上一页 1 2345 10 下一页 到第 查看50页数据
客服热线
189-9650-1917
yyd@wuxuwang.com
ClinicalTrials.gov数据库提供了目前美国临床试验数据库(ClinicalTrials)登记的所有信息.
友情链接: